Literature DB >> 26171024

Contralateral recurrence of aggressive fibromatosis in a young woman: A case report and review of the literature.

Christopher J Schmoyer1, Harmar D Brereton1, Eric W Blomain1.   

Abstract

Aggressive fibromatosis (AF) is a benign non-encapsulated tumor of mesenchymal origin, with a tendency for local spread along fascial planes. Local invasion can lead to extensive morbidity and even mortality due to destruction of the bones, organs and soft tissues. This rare lesion is observed 1,000 times more frequently in patients with familial adenomatous polyposis or Gardner's syndrome due to the inheritance of the adenomatous polyposis coli (APC) gene. While AF does not metastasize, local recurrence is common. Distant recurrence is extremely rare, but is observed in those with a germ line APC mutation. The present study details the case of a 20-year-old woman with a melanoma of the right shoulder, treated definitively with surgery. The patient then developed a painful mass at the surgical site; a surgical biopsy demonstrated that the mass was AF. The patient was treated with surgical resection, radiation therapy, and a course of tamoxifen. Five years later, the patient presented with left forearm pain and diminished range of motion due to an infiltrating mass. This was excised and a clinical diagnosis of recurrent AF was made, in this patient lacking familial predisposition to the disease.

Entities:  

Keywords:  aggressive fibromatosis; case report; contralateral; oncology; recurrence

Year:  2015        PMID: 26171024      PMCID: PMC4487148          DOI: 10.3892/ol.2015.3215

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  The use of indomethacin, sulindac, and tamoxifen for the treatment of desmoid tumors associated with familial polyposis.

Authors:  W A Klein; H H Miller; M Anderson; J J DeCosse
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

2.  Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.

Authors:  Marco Fiore; Françoise Rimareix; Luigi Mariani; Julien Domont; Paola Collini; Cecile Le Péchoux; Paolo G Casali; Axel Le Cesne; Alessandro Gronchi; Sylvie Bonvalot
Journal:  Ann Surg Oncol       Date:  2009-07-01       Impact factor: 5.344

3.  Synchronous multicentric desmoid tumors (aggressive fibromatosis) of the extremities.

Authors:  M Sundaram; H Duffrin; M H McGuire; W Vas
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

4.  Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.

Authors:  Colleen Wu; Saeid Amini-Nik; Saied Nik-Amini; Puviindran Nadesan; William L Stanford; Benjamin A Alman
Journal:  Cancer Res       Date:  2010-09-14       Impact factor: 12.701

5.  Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene.

Authors:  D M Eccles; R van der Luijt; C Breukel; H Bullman; D Bunyan; A Fisher; J Barber; C du Boulay; J Primrose; J Burn; R Fodde
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

6.  Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration.

Authors:  Christopher L Owens; Rajni Sharma; Syed Z Ali
Journal:  Cancer       Date:  2007-06-25       Impact factor: 6.860

7.  Extra-abdominal desmoid fibromatosis: two familial cases with synchronous and metachronous multicentric hyalinizing nodules.

Authors:  K Watanabe; G Ogura; T Tajino; T Suzuki
Journal:  Histopathology       Date:  2002-08       Impact factor: 5.087

8.  Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.

Authors:  Ronak Ghanbari-Azarnier; Shingo Sato; Qingxia Wei; Mushriq Al-Jazrawe; Benjamin A Alman
Journal:  Neoplasia       Date:  2013-07       Impact factor: 5.715

Review 9.  The pharmacological treatment of aggressive fibromatosis: a systematic review.

Authors:  J Janinis; M Patriki; L Vini; G Aravantinos; J S Whelan
Journal:  Ann Oncol       Date:  2003-02       Impact factor: 32.976

10.  Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.

Authors:  B Rubinfeld; I Albert; E Porfiri; C Fiol; S Munemitsu; P Polakis
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.